Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in various therapeutic areas, such as cardiology, orthopaedics, anti-diabetic, ophthalmology, gynaecology, nephrology, gastrology, urology, dermatology, anti-infective, cold and cough, and animal healt… Read more
Alembic Pharmaceuticals Limited (APLLTD) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.076x
Based on the latest financial reports, Alembic Pharmaceuticals Limited (APLLTD) has a cash flow conversion efficiency ratio of 0.076x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹4.03 Billion) by net assets (₹53.16 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Alembic Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Alembic Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Alembic Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Alembic Pharmaceuticals Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SFTCF
PINK:SFTCF
|
0.099x |
|
IMMOFINANZ AG
VI:IIA
|
0.061x |
|
Bravura Solutions Limited
PINK:BVSFF
|
0.357x |
|
Accolade, Inc.
NASDAQ:ACCD
|
-0.031x |
|
Qingdao Doublestar Co Ltd
SHE:000599
|
0.018x |
|
Guangdong LingXiao Pump Industry Co Ltd
SHE:002884
|
0.076x |
|
Guangdong Jiaying Pharmaceutical Co Ltd
SHE:002198
|
-0.065x |
|
MilDef Group AB
ST:MILDEF
|
0.048x |
Annual Cash Flow Conversion Efficiency for Alembic Pharmaceuticals Limited (2011–2025)
The table below shows the annual cash flow conversion efficiency of Alembic Pharmaceuticals Limited from 2011 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹51.90 Billion | ₹879.70 Million | 0.017x | -89.83% |
| 2024-03-31 | ₹48.18 Billion | ₹8.03 Billion | 0.167x | +0.64% |
| 2023-03-31 | ₹43.70 Billion | ₹7.24 Billion | 0.166x | +57.07% |
| 2022-03-31 | ₹52.38 Billion | ₹5.52 Billion | 0.105x | -63.48% |
| 2021-03-31 | ₹50.67 Billion | ₹14.63 Billion | 0.289x | +105.16% |
| 2020-03-31 | ₹31.90 Billion | ₹4.49 Billion | 0.141x | -52.88% |
| 2019-03-31 | ₹27.18 Billion | ₹8.12 Billion | 0.299x | +112.32% |
| 2018-03-31 | ₹22.20 Billion | ₹3.12 Billion | 0.141x | -7.37% |
| 2017-03-31 | ₹19.01 Billion | ₹2.89 Billion | 0.152x | -73.87% |
| 2016-03-31 | ₹16.01 Billion | ₹9.30 Billion | 0.581x | +199.39% |
| 2015-03-31 | ₹8.85 Billion | ₹1.72 Billion | 0.194x | -44.47% |
| 2014-03-31 | ₹6.76 Billion | ₹2.36 Billion | 0.350x | -33.59% |
| 2013-03-31 | ₹5.03 Billion | ₹2.65 Billion | 0.527x | +47.78% |
| 2012-03-31 | ₹3.95 Billion | ₹1.41 Billion | 0.356x | +9.39% |
| 2011-03-31 | ₹2.95 Billion | ₹961.81 Million | 0.326x | -- |